5 March 2026
Credit: Getty Images/Ahmet YaraliBy Olivia Bowthorpe
Patients regain 60% of weight lost on GLP-1 receptor agonist drugs within a year of stopping treatment, according to a systematic review by researchers at the University of Cambridge.
They warned that if the regained weight is predominantly fat, patients could end up with a worse body composition than before starting treatment.